PRESS RELEASE published on 08/28/2025 at 09:30, 6 months 25 days ago Gerresheimer expands financial flexibility to implement growth strategy Gerresheimer optimizes corporate financing by securing EUR 200 million loans to repay part of bridge financing for Bormioli Pharma acquisition ahead of schedule, enhancing financial flexibility for growth strategy implementation Growth Strategy Bormioli Pharma Gerresheimer Corporate Financing Financial Flexibility
BRIEF published on 08/12/2025 at 08:05, 7 months 11 days ago Achim Schalk rejoint le conseil d'administration de Gerresheimer Conseil D'administration Gerresheimer AG Restructuration D'entreprise Verre Moulé Achim Schalk
BRIEF published on 08/12/2025 at 08:05, 7 months 11 days ago Achim Schalk to Join Gerresheimer's Management Board Management Board Gerresheimer AG Corporate Restructuring Moulded Glass Achim Schalk
PRESS RELEASE published on 08/12/2025 at 08:00, 7 months 11 days ago Gerresheimer AG: Achim Schalk To Join the Gerresheimer Management Board Achim Schalk appointed to Gerresheimer Management Board, succeeding Dr. Lukas Burkhardt. Responsible for Moulded Glass, Tubular Glass, and Syringe Systems business units Management Board Gerresheimer AG Moulded Glass Achim Schalk Syringe Systems
BRIEF published on 08/04/2025 at 18:45, 7 months 18 days ago Gerresheimer va séparer son activité de verre moulé Bormioli Pharma Gerresheimer Transformation Stratégique Séparation En Verre Moulé Pharmaceutique Et Biotechnologie
BRIEF published on 08/04/2025 at 18:45, 7 months 18 days ago Gerresheimer to Separate Moulded Glass Business Bormioli Pharma Gerresheimer Strategic Transformation Moulded Glass Separation Pharma And Biotech
PRESS RELEASE published on 08/04/2025 at 18:40, 7 months 18 days ago Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process Gerresheimer to separate its Moulded Glass business and start a sales process for the unit, focusing on the pharma and biotech industries. Strategic company decision for growth opportunities Sales Process Gerresheimer Pharma Moulded Glass Separate
BRIEF published on 08/04/2025 at 18:25, 7 months 18 days ago Gerresheimer AG Plans Sale of Moulded Glass Business Gerresheimer AG Business Divestment Strategic Transformation Pharma Industry Moulded Glass
BRIEF published on 08/04/2025 at 18:25, 7 months 18 days ago Gerresheimer AG envisage de vendre son activité de verre moulé Gerresheimer AG Transformation Stratégique Industrie Pharmaceutique Cession D'entreprise Verre Moulé
PRESS RELEASE published on 08/04/2025 at 18:20, 7 months 18 days ago EQS-Adhoc: Gerresheimer AG to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process Gerresheimer AG to separate moulded glass business and initiate sales process for strategic transformation into pharma and biotech solution provider Sales Process Strategic Decision Divestment Gerresheimer AG Moulded Glass
Published on 03/23/2026 at 08:00, 57 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 6 hours 57 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 08:30, 27 minutes ago Cyberclick and HubSpot Bring Together London Business Leaders to Explore the Next Phase of AI-driven CRM
Published on 03/23/2026 at 08:26, 30 minutes ago Staking Rush in Ontario: Storm Exploration Secures the Prime Plots in the New Gold Belt
Published on 03/23/2026 at 08:20, 37 minutes ago Eurobattery Minerals becomes debt-free as the final convertible bonds are fully converted into shares
Published on 03/23/2026 at 08:00, 56 minutes ago Zentra Group plc: Unaudited interim report for the six months ended 31 December 2025
Published on 03/23/2026 at 08:10, 47 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 13 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 13 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 14 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 14 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
